Inactive Instrument

Highlights ZIVO Bioscience, Inc. Other OTC

Equities

ZIVO

US98978N1019

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-15	CI
ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	02-07	CI
Zivo Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	01-23	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Reverse Split: 1 of 6	23-10-26	FA
Trial Results Confirm Efficacy of ZIVO Bioscience?s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23-09-19	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Zivo Bioscience, Inc. Commences Sales of Its Proprietary Algal Biomass as Human Food	23-07-26	CI
Zivo Bioscience, Inc. Announces its GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as Human Food Ingredient	23-05-30	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
North American Morning Briefing : Stock Futures Hold Steady As Inflation Data Looms	23-02-13	DJ
ZIVO Bioscience, Inc. Announces Results of Study with Its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23-02-10	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
ZIVO Bioscience, Inc. Announces Plans to Create ZIVOLife LLC	22-10-24	CI
ZIVO Bioscience, Inc. Reports USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment	22-08-10	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ZIVO Bioscience, Inc. Other OTC

Equities

ZIVO

US98978N1019

Highlights

Filters